186. Deputy John Brassil asked the Minister for Health his views on the proposal by the HPRA to increase its fees to Irish pharmaceutical companies by 8% in 2019; his plans to grant this increase; the work he has undertaken to analyse the merits of the increase in view of the pressures faced by companies in meeting the challenges of Brexit and by the introduction of the falsified medicines directive in February 2019. [3550/19]

Summary

186. Deputy John Brassil asked the Minister for Health his views on the proposal by the HPRA to increase its fees to Irish pharmaceutical companies by 8% in 2019; his plans to grant this increase; the work he has undertaken to analyse the merits of the increase in view of the pressures faced by companies in meeting the challenges of Brexit and by the introduction of the falsified medicines directive in February 2019. [3550/19]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Pharmaceutical Sector

  xml · EN · 24 January 2019

  ViewDownloadOpen at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.